Klaire Labs SFI Health Ther-Biotic Target B2, 90 Capsules

$24.80 USD
Shipping fees will be calculated at checkout.
  • Free worldwide shipping

  • Free returns

  • Carbon neutral

  • Secure payments

  • Lactation-Focused Probiotic - A targeted probiotic designed to provide lactation support, and extend the benefits of breastfeeding. Developed specifically to help reduce discomfort related to breastfeeding and promote microbial balance in breast tissue.*
  • Targeted Breast Health Support - Clinically formulated with Lactobacillus fermentum to help balance the mammary microbiome and promote comfort during lactation.*
  • Third Trimester to Nursing - It is recommended to start taking this lactation supplement in the third trimester of pregnancy and continue taking daily while nursing.
  • Backed by Clinical Research - Studies have shown that certain lactic acid bacteria species, such as L. fermentum, may help prevent and resolve lactation-associated mammary dysbiosis.*
  • Klaire Labs is Now SFI Health - Klaire Labs has been part of the SFI Health family for many years leading the way in efficacy, safety, quality, and trusted by healthcare practitioners. While we might be changing the way things look, rest assured that our breastfeeding supplements remain the same.
Primary Supplement TypeNursing Support Probiotic
Item FormCapsule
Diet TypeGluten Free, Vegan
Product BenefitsGut Health Support
Age Range DescriptionAdult
Dosage FormCapsule
UPC709616310144
ManufacturerSFI Health
Unit Count90 Count
Item Weight0.04 kg
Number of Items1
FlavorUnflavoured
Material FeaturesNo Artificial Preservatives
Material Type FreeEgg Free, Milk Free, Peanut Free, Soy Free, Tree Nuts Free
Allergen InformationShellfish Free
Price$41.99 $ 41 . 99
Designed For:Infants & Young Children
Product Features:10 species pure probiotic + inulin blend designed to meet the special needs of infants*
Why Choose Klaire Labs?Clean and hypoallergenic for optimal results. Can be easily mixed into breast milk or food.
Hypoallergenic?
Product BenefitGut Health Support
Number Of Items1
Klaire Labs

As many as one third of lactating women experience significant discomfort resulting in premature cessation of breastfeeding. Conventional approaches are frequently ineffective and commonly associated with adverse effects.[1]

Identification of a robust, colonizing probiotic strain serves as the basis for a safe, effective solution to this common, painful, and difficult-to-resolve problem.*

Support Comfort and Connection
Shelf Stable Non-GMO formulation
Setting Quality Standards since 1969

References:

1. Jiménez E, et al. Oral administration of Lactobacillus strains isolated from breast milk as an alternative. Appl Environ Microbiol. 2008,74(15):4650-4655.

2. Martín R, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143(6):754-758.

3. Olivares M, et al. (2016). Lactobacillus fermentum CECT5716, a human milk probiotic strain. Conference Proceedings of IPC2016. Paper presented at the International Scientific Conference on Probiotics and Prebiotics, Budapest (p. 109). IPC2016.

4. Maldonado-Lobón JA, et al. Lactobacillus fermentum CECT5716 reduces Staphylococcus load in the breastmilk of lactating mothers suffering breast pain: a randomized controlled trial. Breastfeed Med. 2015;10(9):425-432.

Example title

Recently viewed

Cart

loading